Microglial activity appears to determine when amyloid becomes biologically significant, reshaping how clinicians interpret ...

Experts predict a test measuring p-tau217 in blood plasma may become a standard screening tool for Alzheimer’s disease in ...

A multi-species synbiotic supplement has led to measurable improvements in weight, metabolic control and cardiovascular risk ...

Blood-based Biomarker for Alzheimer’s Disease Market to reach US$ 554.2 Mn by 2035 at 14.3% CAGR, driven by demand for ...

This population-based study used plasma pTau217 to estimate how common Alzheimer’s disease neuropathological changes are across age and cognitive status in a Norwegian community cohort. Prevalence ...

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), today announced positive updates from the ongoing CIRRUS-HCM, Phase 2 clinical ...

New Australian research has identified simultaneous abnormalities across multiple biological systems in people with myalgic ...

The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...

From GLP-1 weight-loss drugs and mRNA cancer vaccines to longevity science and regenerative medicine, 2025 marked a decisive ...

Rare case shows a man living virus free for years after stopping treatment, raising new questions about how the immune system ...

Long-term data published in JAMA Neurology further illustrate the effects of Biogen’s QALSODY on function, strength, and ...

A Macquarie University–led study has identified coordinated abnormalities in cellular energy, immune function and blood ...